Cargando…
Percutaneous transluminal angioplasty for symptomatic hepatic vein-type Budd-Chiari syndrome: feasibility and long-term outcomes
For management of Budd-Chiari syndrome (BCS), a step-wise therapeutic approach starting with medical treatment, followed by endovascular recanalization, transjugular intrahepatic portosystemic shunt, and finally liver transplantation has been adopted. We retrospectively analyzed 51 patients with sym...
Autores principales: | Elkilany, Aboelyazid, Alwarraky, Mohamed, Denecke, Timm, Geisel, Dominik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388522/ https://www.ncbi.nlm.nih.gov/pubmed/35982064 http://dx.doi.org/10.1038/s41598-022-16818-8 |
Ejemplares similares
-
Correction to: Gadoxetic acid‑enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression
por: Elkilany, Aboelyazid, et al.
Publicado: (2021) -
Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression
por: Elkilany, Aboelyazid, et al.
Publicado: (2020) -
Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report
por: Shirai, Yusaku, et al.
Publicado: (2011) -
Small hepatic veins Budd–Chiari syndrome
por: Riggio, Oliviero, et al.
Publicado: (2013) -
Budd-Chiari syndrome due to hepatic venous web outflow obstruction: percutaneous treatment with balloon angioplasty
por: Metzger, Patrick Bastos, et al.
Publicado: (2021)